Synonyms: MK-7655 | MK-7655A | MK7655
relebactam is an approved drug (FDA (2019), EMA (2020))
Compound class:
Synthetic organic
Comment: Relebactam is a β-lactamase inhibitor [1].
|
|
No information available. |
Summary of Clinical Use ![]() |
Relebactam is currently available for use in the clinic in a combination product which includes imipenem and cilastatin, called Recarbrio®. |
External links ![]() |
For extended ADME data see the following: Drugs.com European Medicines Agency (EMA) |